EPAS1 and neoplasm: Among the tumours (phaeochromocytomas, n = 37; paragangliomas, n = 8), 53% (n = 24/45) showed high levels of EPAS1 mRNA expression, whereas 47% (n = 21/45) had EPAS1 low-level expression.